|
LifeLabs provides advanced cardiac health screening through the early identification of risk factors and the ability to effectively monitor treatments and prevention methods. In partnership with other leading diagnostics providers, LifeLabs is launching four new cardiac markers. When used in conjunction with routine testing, these markers can advance your ability to prevent cardiac events. For more information on these tests or to learn how to order, contact us toll free at 1-877-849-3637.
 |
|
 |
|
PLAC TestTM
The PLAC TestTM is a blood test that measures the level of Lp-PLA2 an enzyme highly specific to vascular inflammation and implicated in the formation of ruptureprone plaque. The PLAC TestTM helps identify patients who have “hidden” cardiovascular risk due to the formation of rupture-prone plaque.
|
|
CardioMPOTM
CardioMPOTM measures the amount of MPO, a leukocyte-derived inflammatory enzyme, in the blood. MPO is a vascular specific marker of vulnerable plaque able to identify patients at risk for a heart attack. MPO enhances cardiovascular risk prediction when used independently or alongside standard biomarker testing.
|
 |
|
 |
|
|
|
Omega-ScoreTM
The Omega-ScoreTM Test quantifies the fatty acids present in a sample of your whole blood. Specific levels of long-chain omega-3 polyunsaturated fatty acids, specifically Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) in the blood have been associated with a lower risk of sudden death from cardiovascular disease (CVD).
|
For more information on these tests or to learn how to order, contact us toll free at 1-877-849-3637.
Tests offered in partnership with
|
